Literature DB >> 27638539

[Metabolome analysis of solid tumors].

J Budczies1.   

Abstract

Metabolomics, the newest of the omics sciences that also include genomics, transcriptomics and proteomics, has matured into a reliable high-throughput technology. Gas chromatography combined with time-of-flight mass spectrometry (GC-TOFMS) is a suitable method to analyze the central metabolism in fresh frozen tumor tissue samples. Bioinformatics methods, including the PROFILE clustering developed by us, permit integrated analysis and fast interpretation of metabolomics data in the context of enzymatic reactions and metabolic pathways. The metabolome analyses of three solid tumor types presented here, together with the results of other authors, show that metabolites are suitable as biomarkers and provide diverse options for translation into the clinical setting.

Entities:  

Keywords:  Beta-alanine; Glutamic acid; Glutaminase inhibitors; Metabolomics; Neoplasms

Mesh:

Substances:

Year:  2016        PMID: 27638539     DOI: 10.1007/s00292-016-0217-1

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  26 in total

Review 1.  Oncometabolites-driven tumorigenesis: From genetics to targeted therapy.

Authors:  Aurélie Morin; Eric Letouzé; Anne-Paule Gimenez-Roqueplo; Judith Favier
Journal:  Int J Cancer       Date:  2014-08-14       Impact factor: 7.396

2.  Targeting mitochondrial glutaminase activity inhibits oncogenic transformation.

Authors:  Jian-Bin Wang; Jon W Erickson; Reina Fuji; Sekar Ramachandran; Ping Gao; Ramani Dinavahi; Kristin F Wilson; Andre L B Ambrosio; Sandra M G Dias; Chi V Dang; Richard A Cerione
Journal:  Cancer Cell       Date:  2010-09-14       Impact factor: 31.743

3.  Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer.

Authors:  Matt I Gross; Susan D Demo; Jennifer B Dennison; Lijing Chen; Tania Chernov-Rogan; Bindu Goyal; Julie R Janes; Guy J Laidig; Evan R Lewis; Jim Li; Andrew L Mackinnon; Francesco Parlati; Mirna L M Rodriguez; Peter J Shwonek; Eric B Sjogren; Timothy F Stanton; Taotao Wang; Jinfu Yang; Frances Zhao; Mark K Bennett
Journal:  Mol Cancer Ther       Date:  2014-02-12       Impact factor: 6.261

4.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

Authors:  Arun Sreekumar; Laila M Poisson; Thekkelnaycke M Rajendiran; Amjad P Khan; Qi Cao; Jindan Yu; Bharathi Laxman; Rohit Mehra; Robert J Lonigro; Yong Li; Mukesh K Nyati; Aarif Ahsan; Shanker Kalyana-Sundaram; Bo Han; Xuhong Cao; Jaeman Byun; Gilbert S Omenn; Debashis Ghosh; Subramaniam Pennathur; Danny C Alexander; Alvin Berger; Jeffrey R Shuster; John T Wei; Sooryanarayana Varambally; Christopher Beecher; Arul M Chinnaiyan
Journal:  Nature       Date:  2009-02-12       Impact factor: 49.962

Review 5.  How cancer metabolism is tuned for proliferation and vulnerable to disruption.

Authors:  Almut Schulze; Adrian L Harris
Journal:  Nature       Date:  2012-11-15       Impact factor: 49.962

6.  Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES).

Authors:  Mary M Robinson; Steven J McBryant; Takashi Tsukamoto; Camilo Rojas; Dana V Ferraris; Sean K Hamilton; Jeffrey C Hansen; Norman P Curthoys
Journal:  Biochem J       Date:  2007-09-15       Impact factor: 3.857

7.  Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: alterations in glutamine and beta-alanine metabolism.

Authors:  Jan Budczies; Scarlet F Brockmöller; Berit M Müller; Dinesh K Barupal; Christiane Richter-Ehrenstein; Anke Kleine-Tebbe; Julian L Griffin; Matej Orešič; Manfred Dietel; Carsten Denkert; Oliver Fiehn
Journal:  J Proteomics       Date:  2013-10-11       Impact factor: 4.044

8.  HMDB 3.0--The Human Metabolome Database in 2013.

Authors:  David S Wishart; Timothy Jewison; An Chi Guo; Michael Wilson; Craig Knox; Yifeng Liu; Yannick Djoumbou; Rupasri Mandal; Farid Aziat; Edison Dong; Souhaila Bouatra; Igor Sinelnikov; David Arndt; Jianguo Xia; Philip Liu; Faizath Yallou; Trent Bjorndahl; Rolando Perez-Pineiro; Roman Eisner; Felicity Allen; Vanessa Neveu; Russ Greiner; Augustin Scalbert
Journal:  Nucleic Acids Res       Date:  2012-11-17       Impact factor: 16.971

9.  MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis.

Authors:  Atsushi Terunuma; Nagireddy Putluri; Prachi Mishra; Ewy A Mathé; Tiffany H Dorsey; Ming Yi; Tiffany A Wallace; Haleem J Issaq; Ming Zhou; J Keith Killian; Holly S Stevenson; Edward D Karoly; King Chan; Susmita Samanta; DaRue Prieto; Tiffany Y T Hsu; Sarah J Kurley; Vasanta Putluri; Rajni Sonavane; Daniel C Edelman; Jacob Wulff; Adrienne M Starks; Yinmeng Yang; Rick A Kittles; Harry G Yfantis; Dong H Lee; Olga B Ioffe; Rachel Schiff; Robert M Stephens; Paul S Meltzer; Timothy D Veenstra; Thomas F Westbrook; Arun Sreekumar; Stefan Ambs
Journal:  J Clin Invest       Date:  2013-12-09       Impact factor: 19.456

10.  An Optimized Method of Metabolite Extraction from Formalin-Fixed Paraffin-Embedded Tissue for GC/MS Analysis.

Authors:  Anna Wojakowska; Łukasz Marczak; Karol Jelonek; Krzysztof Polanski; Piotr Widlak; Monika Pietrowska
Journal:  PLoS One       Date:  2015-09-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.